Tech training needs more dialogue, says CCP

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.

Killian Meara;Jennifer Gershman, PharmD, CPh, PACS;Hailey Choi, PharmD, BCACP, CDCES

CGRP Medication Did Not Prevent Cluster Headache Attacks

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

Ashley Gallagher

The Overarching Implications of PBM Reform on the State Level

Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.

Brian Nowosielski;Brett Barker, PharmD

July 10th 2025

Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.

Ashley Gallagher;Buddy Carter, BSPharm

Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Brian Nowosielski;Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Q&A: Pharmacists Play Essential Role in Insulin Therapy Success

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.

Related Content

Killian Meara;Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.

Killian Meara;Jennifer Gershman, PharmD, CPh, PACS;Hailey Choi, PharmD, BCACP, CDCES

CGRP Medication Did Not Prevent Cluster Headache Attacks

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

Ashley Gallagher

The Overarching Implications of PBM Reform on the State Level

Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.

Brian Nowosielski;Brett Barker, PharmD

July 10th 2025

Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.

Ashley Gallagher;Buddy Carter, BSPharm

Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Brian Nowosielski;Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES